Menon, Ramkumar <br/><br/>
p38 Mitogen activated protein kinase (MAPK): a new therapeutic target for reducing the risk of adverse pregnancy outcomes.  [electronic resource] 

 -  Expert opinion on therapeutic targets  Dec 2016 
 - 1397-1412 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7631 
<br/><br/><label>Standard No.: </label>10.1080/14728222.2016.1216980  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Female<br/>Fetal Membranes, Premature Rupture--prevention & control<br/>Humans<br/>Oxidative Stress--physiology<br/>Pregnancy<br/>Pregnancy Outcome<br/>Premature Birth--prevention & control<br/>Risk Factors<br/>Telomere--metabolism<br/>p38 Mitogen-Activated Protein Kinases--metabolism